Hercules Technology Growth Capital, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on April 20, 2005, by Hercules Technology Growth Capital, Inc. (a Maryland corporation). The report discloses an event that occurred on June 20, 2005, regarding a credit facility secured by a portfolio company.
Key Financial Metrics
The filing does not provide consolidated financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics for Hercules Technology Growth Capital, Inc. The only specific financial figure disclosed relates to a portfolio company transaction: Merrimack Pharmaceuticals secured a $9 million credit facility.
Material Changes
There are no material changes to the registrant's financial condition reported in this document. The filing solely announces the $9 million credit facility secured by Merrimack Pharmaceuticals on June 20, 2005.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies regarding the registrant's future performance. It serves strictly as a notification of the portfolio company event.
Key Facts for Investor Verification
- The registrant is Hercules Technology Growth Capital, Inc., not Hercules Capital, Inc.
- The reported event involves a $9 million credit facility for Merrimack Pharmaceuticals.
- The event date (June 20, 2005) is subsequent to the filing date (April 20, 2005), indicating a potential discrepancy in the source text's timeline or a pre-announcement filing.
- No financial data for the registrant is included in this specific 8-K.